The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target.
Authors
Legoffic A, Calvo E, Cano C, Folch-Puy E, Barthet M, Delpero JR, Ferrés-Masó M, Dagorn JC, Closa D, Iovanna J
Summary
The aim of our work was to identify the genes specifically altered in pancreatic adenocarcinoma and especially those that are altered early in cancer development.
Read the article